PMC's Annual State of Personalized Medicine Luncheon Address at the National Press Club provides a forum for attendees from across the health care spectrum to engage health care leaders in a discussion of the issues facing the field.
At the 14th Annual State of Personalized Medicine Luncheon, titled Public Perspectives on Personalized Medicine: A Public Opinion Survey Launch Event, PMC unveiled the results of a representative survey of 1,001 Americans that explored awareness of personalized medicine, reactions to value propositions based on the field’s ability to improve the quality and cost of health care, and concerns related to ethics, privacy and access.
Eric Dishman, Director, All of Us Research Program, U.S. National Institutes of Health (2017)
Stephen J. Ubl, President, CEO, PhRMA (2016)
Michael C. Burgess, M.D., Member, U.S. House of Representatives (2015)
Patrick Conway, M.D., Deputy Administrator for Innovation and Quality, Chief Medical Officer, U.S. Centers for Medicare & Medicaid Services (2014)
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration (2013)
Mark Levin, Partner, Third Rock Ventures (2012)
John Castellani, President, CEO, PhRMA (2011)
Margaret Hamburg, M.D., Commissioner, U.S. Food and Drug Administration (2010)
Denis Cortese, M.D., President, CEO, Mayo Clinic (2009)
Harvey Fineberg, M.D., President, Institute of Medicine (2008)
Michael O. Leavitt, Secretary, U.S. Department of Health and Human Services (2007)
Andrew von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration (2006)
Francis Collins, M.D., Ph.D., Director, National Human Genome Research Institute (2005)